-
Industries
- Automotive
- Banking
- Capital Markets
- Communications, Media & Technology
- Consumer Goods
- Education
- Healthcare
- Information Services
- Insurance
- Life Sciences
- Manufacturing
- Oil & Gas
- Retail
- Transportation & Logistics
- Travel & Hospitality
- Utilities
-
-
COGNIZANT CONSULTING
Helping organizations engage people and uncover insight from data to shape the products, services and experiences they offer
Learn More
-
Services
Digital Business & Technology
- Application Services & Modernization
- Artificial Intelligence
- Cloud Enablement
- Cognizant Infrastructure Services
- Cognizant Security
- Core Modernization
- Digital Engineering
- Digital Experience
- Digital Strategy
- Enterprise Application Services
- Internet of Things
- Quality Engineering & Assurance
Digital Business Operations
- Business Process Services
- Enterprise Services
- Industry & Platform Solutions
- Intelligent Process Automation
-
COGNIZANT CONSULTING
Helping organizations engage people and uncover insight from data to shape the products, services and experiences they offer
Learn More
-
Latest Thinking
-
Our Media & Publications
- All Latest Thinking
- Browse Case Studies
- Cognizant Podcasts
- Cognizanti Journal
- Digitally Cognizant Blog
- Infographics
- Perspectives
-
Key Themes
- Code Halos
- Digital Maturity Research
- When Machines Do Everything
- World Economic Forum—Davos
-
Center for the Future of Work
- 21 More Jobs of the Future
- Digital Workforce of the Future
- Explore the Future of Work
- Jobs of the Future Index
- Our Post-COVID Future
- The Work Ahead
-
-
- About
Please visit the COVID-19 response page for resources and advice on managing through the crisis today and beyond.
UNIFIED TRIAL MANAGEMENT
Cognizant® Shared Investigator Platform
Bridging the Path from Sponsor eTMF to Site eISF Systems
The Cognizant SIP eISF Connect module addresses document exchange and collaboration challenges by providing a bridge between sponsor eTMF systems and the Florence eISF system.
VIEW SOLUTION OVERVIEWA new way forward
In light of the pandemic and technology breakthroughs such as AI and remote collaboration, life sciences organizations around the world are reconsidering how they conduct clinical trials.
Cognizant’s Shared Investigator Platform supports a new approach for streamlining clinical trials. As the industry’s first open, SaaS-based clinical ecosystem, Cognizant SIP connects sponsors, sites and technology providers working at home or other locations. It does so all from one place, with one sign-in.
Many leading life sciences companies have joined SIP, committing to a shared vision of common workflows, training and documents. Sponsors and sites report improved efficiencies and quicker study start-ups. The result? Faster time to market for new therapies—and more time helping patients.
Learn more about our Life Sciences solutions for your business.
Growth remains strong for Cognizant SIP in 2021
Cognizant SIP has maintained its growth momentum in 2021 as research sites have continued their adoption of the platform at a steady pace.
VIEW INFOGRAPHICRecently published insights
Streamline clinical trials with a site-first approach
View on-demand: 2021 Cognizant SIP user group meeting sessions—SIP Synergy: Collaborate. Inspire. Innovate.
View the event where industry-leading sites, sponsors, research organizations and SIP product leaders came together to explore the future of clinical trials and discuss how SIP facilitates the transition to decentralized trials.
REGISTER TO VIEW EVENT ON-DEMAND
Improve efficiency to accelerate clinical trials
Learn from industry leaders how the Shared Investigator Platform standardizes documents, eliminates inconsistencies and speeds clinical trials.
WATCH VIDEO
Decentralized clinical trials, powered by SIP
Learn how to unlock your operational inefficiencies and operate remotely in the new normal with Cognizant SIP.
VIEW WEBINAR
Reducing complexity in starting clinical trials
Cognizant SIP solutions for virtual monitoring, study oversight, document exchange and collaboration, and Oracle’s study startup workflows and predictive analytics, improve clinical trial efficiencies and enable stakeholders to conduct studies virtually.
VIEW WEBINAR
More studies. Less duplication
Shared Investigator Platform (SIP) is a multi-sponsor collaborative solution for clinical trial site selection, start-up communications and management. The open design of Cognizant’s Shared Investigator Platform simplifies and accelerates clinical trials by eliminating redundant work for sponsors and clinical sites.
WATCH VIDEO
Cognizant® Shared Investigator Platform
Learn how the Cognizant® Shared Investigator Platform helps sponsors meet today’s challenges while providing a better trial experience for clinical researchers.
READ BROCHURE
One Clinical Trial Operations Platform with Cognizant SIP
Learn how Cognizant® Shared Investigator Platform makes it easy for sites to collaborate with sponsors.
READ BROCHURE
Modernize operations with Cognizant® Shared Investigator Platform
Cognizant SIP is a robust platform that transforms how sponsors and sites collaborate throughout key components of the clinical trial lifecycle.
READ DATASHEET
Implementing Cognizant® Shared Investigator Platform: Lessons from the Field
A leading oncology healthcare system and research institution shares its best practices around planning for and successfully implementing Cognizant SIP at a large organization.
READ PAPER
Integrated Video Meetings Capability in Cognizant® Shared Investigator Platform
The COVID-19 pandemic has forced sponsors to find new ways to virtually visit investigators. The video meeting capability in Cognizant SIP streamlines and optimizes collaboration throughout the clinical trial life cycle.
READ DATASHEETRelated thinking
Reinventing clinical trials for a stay-at-home world
As current social distancing guidelines prevent most face-to-face clinical trials, now’s the time to move to decentralized clinical trials.
Accelerating clinical trials: The new and future normal
Keeping clinical trials operating efficiently during the COVID-19 pandemic is forcing the life sciences industry to adopt new working practices.
